Danaher Co. (NYSE:DHR) Shares Bought by FSM Wealth Advisors LLC

FSM Wealth Advisors LLC raised its position in Danaher Co. (NYSE:DHR) by 1.0% in the 4th quarter, Holdings Channel.com reports. The fund owned 5,889 shares of the conglomerate’s stock after acquiring an additional 60 shares during the quarter. FSM Wealth Advisors LLC’s holdings in Danaher were worth $1,424,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of DHR. FMR LLC lifted its stake in shares of Danaher by 15.8% during the third quarter. FMR LLC now owns 23,617,424 shares of the conglomerate’s stock worth $6,566,116,000 after buying an additional 3,217,631 shares during the period. Massachusetts Financial Services Co. MA raised its holdings in shares of Danaher by 17.6% during the third quarter. Massachusetts Financial Services Co. MA now owns 3,582,982 shares of the conglomerate’s stock worth $996,141,000 after purchasing an additional 535,254 shares during the last quarter. International Assets Investment Management LLC raised its holdings in shares of Danaher by 40,196.5% during the third quarter. International Assets Investment Management LLC now owns 429,964 shares of the conglomerate’s stock worth $119,539,000 after purchasing an additional 428,897 shares during the last quarter. Montrusco Bolton Investments Inc. raised its holdings in shares of Danaher by 30.4% during the third quarter. Montrusco Bolton Investments Inc. now owns 1,705,884 shares of the conglomerate’s stock worth $465,617,000 after purchasing an additional 397,671 shares during the last quarter. Finally, Union Bancaire Privee UBP SA purchased a new position in shares of Danaher during the fourth quarter worth $74,551,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Stock Down 0.2 %

DHR stock opened at $222.56 on Monday. The stock has a market capitalization of $160.75 billion, a P/E ratio of 42.15, a P/E/G ratio of 4.22 and a beta of 0.83. The firm has a 50-day simple moving average of $235.40 and a 200-day simple moving average of $253.08. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32. Danaher Co. has a 52 week low of $221.34 and a 52 week high of $281.70.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.72%. During the same quarter last year, the firm earned $2.09 EPS. Equities analysts forecast that Danaher Co. will post 8.15 earnings per share for the current fiscal year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, January 31st. Investors of record on Friday, December 27th were given a dividend of $0.27 per share. The ex-dividend date of this dividend was Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a yield of 0.49%. Danaher’s payout ratio is presently 20.45%.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on DHR. Royal Bank of Canada reissued an “outperform” rating and set a $277.00 target price (down previously from $299.00) on shares of Danaher in a report on Thursday. JPMorgan Chase & Co. reduced their target price on shares of Danaher from $310.00 to $300.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Wells Fargo & Company reduced their target price on shares of Danaher from $280.00 to $240.00 and set an “equal weight” rating for the company in a report on Thursday. Raymond James reduced their target price on shares of Danaher from $300.00 to $275.00 and set an “outperform” rating for the company in a report on Tuesday, January 21st. Finally, Scotiabank started coverage on shares of Danaher in a report on Monday, December 23rd. They issued a “sector perform” rating and a $265.00 price objective for the company. Six equities research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company. According to MarketBeat.com, Danaher currently has a consensus rating of “Moderate Buy” and a consensus target price of $278.00.

Insider Buying and Selling

In related news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the transaction, the senior vice president now directly owns 20,230 shares in the company, valued at approximately $4,534,149.90. The trade was a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 11.10% of the stock is currently owned by company insiders.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.